Biomimetic Molybdenum Sulfide‐Catalyzed Tumor Ferroptosis and Bioimaging
Small · 2023
DOI: 10.1002/smll.202207544 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, 2023. Verfasst von Yan Xu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Tongji Hospital, Shanghai Frontiers Science Center of Nanocatalytic Medicine, The Institute for Biomedical Engineering & Nan…. Hauptthemen laut MEDLINE: Ferroptosis, Neoplasms. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 60 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Program of Shanghai Academic Research Leader, Natural Science Foundation of Shanghai.
Abstract (Originalsprache)
The chemical generation of singlet oxygen ( 1 O 2 ) by the MoO 4 2− ‐catalyzed disproportionation of hydrogen peroxide (H 2 O 2 ) has been widely applied in numerous catalytic processes; however, such molybdate ions cannot be administered for redox‐based cancer therapeutics. This work reports the albumin‐mediated biomimetic synthesis of highly active molybdenum sulfide (denoted MoB) nanocatalysts that mediate the simultaneous generation of 1 O 2 and superoxide anion (O 2 •− ) from H 2 O 2 , which is relatively abundant in malignant tumors. The MoB‐catalyzed reactive oxygen species (ROS) are able to activate the ferroptosis pathway and cause lipid peroxidation for efficient cancer therapy. Furthermore, for the first time, the catalytic activity of MoB is visualized in situ. Moreover, a catalytic imaging modality based on MoB is developed for specific imaging of inflammation diseases without background interference. Therefore, this study presents a biomimetic strategy toward Mo‐based nanocatalysts for ROS‐facilitated tumor ferroptosis and catalytic imaging.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiology, Tongji Hospital, Shanghai Frontiers Science Center of Nanocatalytic Medicine, The Institute for Biomedical Engineering & Nano Science, School of Medicine, Tongji University, Shanghai, 200065, Ch…
- Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai, 200072, China.
ORCID-Profile: Bingbo Zhang
Förderung
- National Natural Science Foundation of China
- Program of Shanghai Academic Research Leader
- Natural Science Foundation of Shanghai
- Fundamental Research Funds for the Central Universities
Zitieren
APA
Xu, Y., Yang, W., Han, Y., Bian, K., Zeng, W., Hao, L., Wang, H., Cheng, Y., Wang, P., & Zhang, B. (2023). Biomimetic Molybdenum Sulfide‐Catalyzed Tumor Ferroptosis and Bioimaging. Small. https://doi.org/10.1002/smll.202207544
Vancouver
Xu Y, Yang W, Han Y, Bian K, Zeng W, Hao L, et al. Biomimetic Molybdenum Sulfide‐Catalyzed Tumor Ferroptosis and Bioimaging. Small. 2023. doi:10.1002/smll.202207544
BibTeX
@article{Xu2023,
author = {Xu, Yan and Yang, Weitao and Han, Yi and Bian, Kexin and Zeng, Weiwei and Hao, Liangwen and Wang, Hui and Cheng, Yingsheng and Wang, Peijun and Zhang, Bingbo},
title = {Biomimetic Molybdenum Sulfide‐Catalyzed Tumor Ferroptosis and Bioimaging},
journal = {Small},
year = {2023},
doi = {10.1002/smll.202207544}
}
EUVIMED